2,622
Views
34
CrossRef citations to date
0
Altmetric
Review

The advantageous role of annexin A1 in cardiovascular disease

, , &
Pages 261-274 | Received 12 Sep 2016, Accepted 03 Nov 2016, Published online: 21 Dec 2016

References

  • Writing Group M, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation 2016; 133:e38-60; PMID:26673558; https://doi.org/10.1161/CIR.0000000000000350
  • Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res 2014; 114:1852-66; PMID:24902970; https://doi.org/10.1161/CIRCRESAHA.114.302721
  • Navarese EP, Kolodziejczak M, Schulze V, Gurbel PA, Tantry U, Lin Y, Brockmeyer M, Kandzari DE, Kubica JM, D'Agostino RB, Sr., et al. Effects of proprotein convertase subtilisin/kexin type 9 antibodies in adults with hypercholesterolemia: a systematic review and meta-analysis. Ann Intern Med 2015; 163:40-51; PMID:25915661; https://doi.org/10.7326/M14-2957
  • Pedersen TR. The success story of LDL cholesterol lowering. Circ Res 2016; 118:721-31; PMID:26892969; https://doi.org/10.1161/CIRCRESAHA.115.306297
  • Shapiro MD, Fazio S. From lipids to inflammation: new approaches to reducing atherosclerotic risk. Circ Res 2016; 118:732-49; PMID:26892970; https://doi.org/10.1161/CIRCRESAHA.115.306471
  • Ross R. Atherosclerosis–an inflammatory disease. N Engl J Med 1999; 340:115-26; PMID:9887164; https://doi.org/10.1056/NEJM199901143400207
  • Soehnlein O. Multiple roles for neutrophils in atherosclerosis. Circ Res 2012; 110:875-88; PMID:22427325; https://doi.org/10.1161/CIRCRESAHA.111.257535
  • Drechsler M, Megens RT, van Zandvoort M, Weber C, Soehnlein O. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 2010; 122:1837-45; PMID:20956207; https://doi.org/10.1161/CIRCULATIONAHA.110.961714
  • Doring Y, Drechsler M, Wantha S, Kemmerich K, Lievens D, Vijayan S, Gallo RL, Weber C, Soehnlein O. Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice. Circ Res 2012; 110:1052-6; PMID:22394519; https://doi.org/10.1161/CIRCRESAHA.112.265868
  • Viola J, Soehnlein O. Atherosclerosis - A matter of unresolved inflammation. Semin Immunol 2015; 27:184-93; PMID:25865626; https://doi.org/10.1016/j.smim.2015.03.013
  • Ortega-Gomez A, Perretti M, Soehnlein O. Resolution of inflammation: an integrated view. EMBO Mol Med 2013; 5:661-74; PMID:23592557; https://doi.org/10.1002/emmm.201202382
  • Gerke V, Creutz CE, Moss SE. Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 2005; 6:449-61; PMID:15928709; https://doi.org/10.1038/nrm1661
  • Flower RJ, Blackwell GJ. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 1979; 278:456-9; PMID:450050
  • Perretti M, D'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 2009; 9:62-70; PMID:19104500; https://doi.org/10.1038/nri2470
  • Goulding NJ, Godolphin JL, Sampson MB, Maddison P, Flower RJ. Hydrocortisone induces lipocortin 1 production by peripheral blood mononuclear cells in vivo in man. Biochem Soc Trans 1990; 18:306-7; PMID:2143158
  • Solito E, de Coupade C, Parente L, Flower RJ, Russo-Marie F. IL-6 stimulates annexin 1 expression and translocation and suggests a new biological role as class II acute phase protein. Cytokine 1998; 10:514-21; PMID:9702415; https://doi.org/10.1006/cyto.1997.0325
  • Morand EF, Hutchinson P, Hargreaves A, Goulding NJ, Boyce NW, Holdsworth SR. Detection of intracellular lipocortin 1 in human leukocyte subsets. Clin Immunol Immunopathol 1995; 76:195-202; PMID:7614738
  • Oliani SM, Ciocca GA, Pimentel TA, Damazo AS, Gibbs L, Perretti M. Fluctuation of annexin-A1 positive mast cells in chronic granulomatous inflammation. Inflamm Res 2008; 57:450-6; PMID:18827967; https://doi.org/10.1007/s00011-008-7222-7
  • Pan B, Kong J, Jin J, Kong J, He Y, Dong S, Ji L, Liu D, He D, Kong L, et al. A novel anti-inflammatory mechanism of high density lipoprotein through up-regulating annexin A1 in vascular endothelial cells. Biochim Biophys Acta 2016; 1861:501-12; PMID:27012521; PMID:8093248; https://doi.org/10.1016/j.bbalip.2016.03.022
  • Futter CE, Felder S, Schlessinger J, Ullrich A, Hopkins CR. Annexin I is phosphorylated in the multivesicular body during the processing of the epidermal growth factor receptor. J Cell Biol 1993; 120:77-83
  • Patal R, Szyper-Kravitz M. [The dilemma regarding treatment of pulmonary embolism among elderly patients]. Harefuah 2011; 150:572–3, 618
  • Vong L, D'Acquisto F, Pederzoli-Ribeil M, Lavagno L, Flower RJ, Witko-Sarsat V, Perretti M. Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase 3. J Biol Chem 2007; 282:29998-30004; PMID:17681950; https://doi.org/10.1074/jbc.M702876200
  • Rescher U, Goebeler V, Wilbers A, Gerke V. Proteolytic cleavage of annexin 1 by human leukocyte elastase. Biochim Biophys Acta 2006; 1763:1320-4; PMID:17023068; https://doi.org/10.1016/j.bbamcr.2006.08.041
  • Uemura K, Inagaki H, Wada Y, Nakanishi K, Asai K, Kato T, Ando Y, Kannagi R. Identification of immuno-reactive lipocortin 1-like molecules in serum and plasma by an enzyme immunoassay for lipocortin 1. Biochim Biophys Acta 1992; 1119:250-5; PMID:1532130
  • Christmas P, Callaway J, Fallon J, Jones J, Haigler HT. Selective secretion of annexin 1, a protein without a signal sequence, by the human prostate gland. J Biol Chem 1991; 266:2499-507; PMID:1824943
  • Romisch J, Schuler E, Bastian B, Burger T, Dunkel FG, Schwinn A, Hartmann AA, Paques EP. Annexins I to VI: quantitative determination in different human cell types and in plasma after myocardial infarction. Blood Coagul Fibrinolysis 1992; 3:11-7; PMID:1623112
  • Wein S, Fauroux M, Laffitte J, de Nadai P, Guaini C, Pons F, Comera C. Mediation of annexin 1 secretion by a probenecid-sensitive ABC-transporter in rat inflamed mucosa. Biochem Pharmacol 2004; 67:1195-202; PMID:15006554; https://doi.org/10.1016/j.bcp.2003.11.015
  • Chapman LP, Epton MJ, Buckingham JC, Morris JF, Christian HC. Evidence for a role of the adenosine 5′-triphosphate-binding cassette transporter A1 in the externalization of annexin I from pituitary folliculo-stellate cells. Endocrinology 2003; 144:1062-73; PMID:12586783; https://doi.org/10.1210/en.2002-220650
  • Solito E, Christian HC, Festa M, Mulla A, Tierney T, Flower RJ, Buckingham JC. Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface. FASEB J 2006; 20:1498-500; PMID:16720734; https://doi.org/10.1096/fj.05-5319fje
  • de Torre-Minguela C, Barbera-Cremades M, Gomez AI, Martin-Sanchez F, Pelegrin P. Macrophage activation and polarization modify P2X7 receptor secretome influencing the inflammatory process. Sci Rep 2016; 6:22586; PMID:26935289; https://doi.org/10.1038/srep22586
  • Perretti M, Christian H, Wheller SK, Aiello I, Mugridge KG, Morris JF, Flower RJ, Goulding NJ. Annexin I is stored within gelatinase granules of human neutrophil and mobilized on the cell surface upon adhesion but not phagocytosis. Cell Biol Int 2000; 24:163-74; PMID:10772777; PMID:8898757; https://doi.org/10.1006/cbir.1999.0468
  • Perretti M, Croxtall JD, Wheller SK, Goulding NJ, Hannon R, Flower RJ. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat Med 1996; 2:1259-62
  • Oliani SM, Perretti M. Cell localization of the anti-inflammatory protein annexin 1 during experimental inflammatory response. Ital J Anat Embryol 2001; 106:69-77; PMID:11729999
  • Brancaleone V, Dalli J, Bena S, Flower RJ, Cirino G, Perretti M. Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature. J Immunol 2011; 186:4905-14; PMID:21398608; PMID:12595246; https://doi.org/10.4049/jimmunol.1003145
  • Rosengarth A, Luecke H. A calcium-driven conformational switch of the N-terminal and core domains of annexin A1. J Mol Biol 2003; 326:1317-25
  • Leoni G, Neumann PA, Kamaly N, Quiros M, Nishio H, Jones HR, Sumagin R, Hilgarth RS, Alam A, Fredman G, et al. Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. J Clin Invest 2015; 125:1215-27; PMID:25664854; https://doi.org/10.1172/JCI76693
  • Dalli J, Montero-Melendez T, Norling LV, Yin X, Hinds C, Haskard D, Mayr M, Perretti M. Heterogeneity in neutrophil microparticles reveals distinct proteome and functional properties. Mol Cell Proteomics 2013; 12:2205-19; PMID:23660474; https://doi.org/10.1074/mcp.M113.028589
  • Dalli J, Norling LV, Renshaw D, Cooper D, Leung KY, Perretti M. Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles. Blood 2008; 112:2512-9; PMID:18594025; https://doi.org/10.1182/blood-2008-02-140533
  • Headland SE, Jones HR, Norling LV, Kim A, Souza PR, Corsiero E, Gil CD, Nerviani A, Dell'Accio F, Pitzalis C, et al. Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis. Sci Transl Med 2015; 7:315ra190; https://doi.org/10.1126/scitranslmed.aac5608
  • Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, Parmentier M, Serhan CN, Murphy PM. International union of basic and clinical pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 2009; 61:119-61; PMID:19498085; https://doi.org/10.1124/pr.109.001578
  • Dalli J, Montero-Melendez T, McArthur S, Perretti M. Annexin A1 N-terminal derived Peptide ac2-26 exerts chemokinetic effects on human neutrophils. Front Pharmacol 2012; 3:28; PMID:22403546; https://doi.org/10.3389/fphar.2012.00028
  • Ernst S, Lange C, Wilbers A, Goebeler V, Gerke V, Rescher U. An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family. J Immunol 2004; 172:7669-76; PMID:15187149
  • Carp H. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J Exp Med 1982; 155:264-75; PMID:6274994
  • Galper JB. Mitochondrial protein synthesis in HeLa cells. J Cell Biol 1974; 60:755-63; PMID:4824294
  • Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464:104-7; PMID:20203610; https://doi.org/10.1038/nature08780
  • McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CC, Beck PL, Muruve DA, Kubes P. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 2010; 330:362-6; PMID:20947763; https://doi.org/10.1126/science.1195491
  • Chiang N, Serhan CN, Dahlen SE, Drazen JM, Hay DW, Rovati GE, Shimizu T, Yokomizo T, Brink C. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol Rev 2006; 58:463-87; PMID:16968948; https://doi.org/10.1124/pr.58.3.4
  • Cooray SN, Gobbetti T, Montero-Melendez T, McArthur S, Thompson D, Clark AJ, Flower RJ, Perretti M. Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses. Proc Natl Acad Sci U S A 2013; 110:18232-7; PMID:24108355; https://doi.org/10.1073/pnas.1308253110
  • Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007; 7:678-89; https://doi.org/10.1038/nri2156; PMID:17717539
  • Phillipson M, Kubes P. The neutrophil in vascular inflammation. Nat Med 2011; 17:1381-90; PMID:22064428; https://doi.org/10.1038/nm.2514
  • Hajishengallis G, Chavakis T. Endogenous modulators of inflammatory cell recruitment. Trends Immunol 2013; 34:1-6; PMID:22951309; https://doi.org/10.1016/j.it.2012.08.003
  • Kempf T, Zarbock A, Widera C, Butz S, Stadtmann A, Rossaint J, Bolomini-Vittori M, Korf-Klingebiel M, Napp LC, Hansen B, et al. GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat Med 2011; 17:581-8; PMID:21516086; https://doi.org/10.1038/nm.2354
  • Choi EY, Chavakis E, Czabanka MA, Langer HF, Fraemohs L, Economopoulou M, Kundu RK, Orlandi A, Zheng YY, Prieto DA, et al. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 2008; 322:1101-4; PMID:19008446; https://doi.org/10.1126/science.1165218
  • Perretti M, Ahluwalia A, Harris JG, Goulding NJ, Flower RJ. Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody. J Immunol 1993; 151:4306-14; PMID:8409403
  • Harris JG, Flower RJ, Perretti M. Alteration of neutrophil trafficking by a lipocortin 1 N-terminus peptide. Eur J Pharmacol 1995; 279:149-57; PMID:7556395
  • Getting SJ, Flower RJ, Perretti M. Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1. Br J Pharmacol 1997; 120:1075-82; PMID:9134220; https://doi.org/10.1038/sj.bjp.0701029
  • Yang Y, Hutchinson P, Morand EF. Inhibitory effect of annexin I on synovial inflammation in rat adjuvant arthritis. Arthritis Rheum 1999; 42:1538-44; PMID:10403283; https://doi.org/10.1002/1529-0131(199907)42:73.0.CO;2-3
  • Perretti M, Getting SJ, Solito E, Murphy PM, Gao JL. Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics. Am J Pathol 2001; 158:1969-73; PMID:11395373; https://doi.org/10.1016/S0002-9440(10)64667-6
  • Perretti M, Wheller SK, Choudhury Q, Croxtall JD, Flower RJ. Selective inhibition of neutrophil function by a peptide derived from lipocortin 1 N-terminus. Biochem Pharmacol 1995; 50:1037-42; PMID:7575659
  • Hayhoe RP, Kamal AM, Solito E, Flower RJ, Cooper D, Perretti M. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood 2006; 107:2123-30; PMID:16278303; https://doi.org/10.1182/blood-2005-08-3099
  • Kusters DH, Chatrou ML, Willems BA, De Saint-Hubert M, Bauwens M, van der Vorst E, Bena S, Biessen EA, Perretti M, Schurgers LJ, et al. Pharmacological Treatment with Annexin A1 Reduces Atherosclerotic Plaque Burden in LDLR−/− Mice on Western Type Diet. PLoS One 2015; 10:e0130484; PMID:26090792; https://doi.org/10.1371/journal.pone.0130484
  • Walther A, Riehemann K, Gerke V. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol Cell 2000; 5:831-40; PMID:10882119
  • Lim LH, Solito E, Russo-Marie F, Flower RJ, Perretti M. Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc Natl Acad Sci U S A 1998; 95:14535-9; PMID:9826735
  • Gavins FN, Yona S, Kamal AM, Flower RJ, Perretti M. Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. Blood 2003; 101:4140-7; PMID:12560218; https://doi.org/10.1182/blood-2002-11-3411
  • Drechsler M, de Jong R, Rossaint J, Viola JR, Leoni G, Wang JM, Grommes J, Hinkel R, Kupatt C, Weber C, et al. Annexin A1 counteracts chemokine-induced arterial myeloid cell recruitment. Circ Res 2015; 116:827-35; PMID:10903766; https://doi.org/10.1161/CIRCRESAHA.116.305825
  • Solito E, Romero IA, Marullo S, Russo-Marie F, Weksler BB. Annexin 1 binds to U937 monocytic cells and inhibits their adhesion to microvascular endothelium: involvement of the alpha 4 beta 1 integrin. J Immunol 2000; 165:1573-81
  • Hannon R, Croxtall JD, Getting SJ, Roviezzo F, Yona S, Paul-Clark MJ, Gavins FN, Perretti M, Morris JF, Buckingham JC, et al. Aberrant inflammation and resistance to glucocorticoids in annexin 1−/− mouse. FASEB J 2003; 17:253-5; PMID:12475898; https://doi.org/10.1096/fj.02-0239fje
  • Chatterjee BE, Yona S, Rosignoli G, Young RE, Nourshargh S, Flower RJ, Perretti M. Annexin 1-deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro. J Leukoc Biol 2005; 78:639-46; PMID:16000391; https://doi.org/10.1189/jlb.0405206
  • Yang Y, Leech M, Hutchinson P, Holdsworth SR, Morand EF. Antiinflammatory effect of lipocortin 1 in experimental arthritis. Inflammation 1997; 21:583-96; PMID:9429906
  • Leoni G, Alam A, Neumann PA, Lambeth JD, Cheng G, McCoy J, Hilgarth RS, Kundu K, Murthy N, Kusters D, et al. Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. J Clin Invest 2013; 123:443-54; PMID:23241962; https://doi.org/10.1172/JCI65831
  • Mancuso F, Flower RJ, Perretti M. Leukocyte transmigration, but not rolling or adhesion, is selectively inhibited by dexamethasone in the hamster post-capillary venule. Involvement of endogenous lipocortin 1. J Immunol 1995; 155:377-86; PMID:7602112
  • Vital SA, Becker F, Holloway PM, Russell J, Perretti M, Granger DN, Gavins FN. Formyl-Peptide Receptor 2/3/Lipoxin A4 Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease. Circulation 2016; 133:2169-79; PMID:27154726; https://doi.org/10.1161/CIRCULATIONAHA.115.020633
  • Gavins FN, Hughes EL, Buss NA, Holloway PM, Getting SJ, Buckingham JC. Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1-FPR2/ALX anti-inflammatory system. FASEB J 2012; 26:4977-89; PMID:22964301; https://doi.org/10.1096/fj.12-205971
  • Dalli J, Consalvo AP, Ray V, Di Filippo C, D'Amico M, Mehta N, Perretti M. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor. J Immunol 2013; 190:6478-87; PMID:23686496; https://doi.org/10.4049/jimmunol.1203000
  • Smith HK, Gil CD, Oliani SM, Gavins FN. Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke. FASEB J 2015; 29:2161-71; PMID:25690650; https://doi.org/10.1096/fj.14-263160
  • Gastardelo TS, Damazo AS, Dalli J, Flower RJ, Perretti M, Oliani SM. Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation. Am J Pathol 2009; 174:177-83; PMID:19095957; https://doi.org/10.2353/ajpath.2009.080342
  • Dufton N, Hannon R, Brancaleone V, Dalli J, Patel HB, Gray M, D'Acquisto F, Buckingham JC, Perretti M, Flower RJ. Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation. J Immunol 2010; 184:2611-9; PMID:20107188; https://doi.org/10.4049/jimmunol.0903526
  • Jilma B, Voltmann J, Albinni S, Stohlawetz P, Schwarzinger I, Gleiter CH, Rauch A, Eichler HG, Wagner OF. Dexamethasone down-regulates the expression of L-selectin on the surface of neutrophils and lymphocytes in humans. Clin Pharmacol Ther 1997; 62:562-8; PMID:9390113; https://doi.org/10.1016/S0009-9236(97)90052-7
  • de Coupade C, Solito E, Levine JD. Dexamethasone enhances interaction of endogenous annexin 1 with L-selectin and triggers shedding of L-selectin in the monocytic cell line U-937. Br J Pharmacol 2003; 140:133-45; PMID:12967943; https://doi.org/10.1038/sj.bjp.0705413
  • Strausbaugh HJ, Rosen SD. A potential role for annexin 1 as a physiologic mediator of glucocorticoid-induced L-selectin shedding from myeloid cells. J Immunol 2001; 166:6294-300; PMID:11342653
  • Zouki C, Ouellet S, Filep JG. The anti-inflammatory peptides, antiflammins, regulate the expression of adhesion molecules on human leukocytes and prevent neutrophil adhesion to endothelial cells. FASEB J 2000; 14:572-80; PMID:10698973
  • Peshavariya HM, Taylor CJ, Goh C, Liu GS, Jiang F, Chan EC, Dusting GJ. Annexin peptide Ac2-26 suppresses TNFalpha-induced inflammatory responses via inhibition of Rac1-dependent NADPH oxidase in human endothelial cells. PLoS One 2013; 8:e60790; PMID:23637767; https://doi.org/10.1371/journal.pone.0060790
  • Ed Rainger G, Chimen M, Harrison MJ, Yates CM, Harrison P, Watson SP, Lordkipanidze M, Nash GB. The role of platelets in the recruitment of leukocytes during vascular disease. Platelets 2015; 26:507-20; PMID:26196409; https://doi.org/10.3109/09537104.2015.1064881
  • Schober A, Manka D, von Hundelshausen P, Huo Y, Hanrath P, Sarembock IJ, Ley K, Weber C. Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation 2002; 106:1523-9; PMID:12234959
  • Murphy CT, Peers SH, Forder RA, Flower RJ, Carey F, Westwick J. Evidence for the presence and location of annexins in human platelets. Biochem Biophys Res Commun 1992; 189:1739-46; PMID:1482379
  • Eldering JA, Kocher M, Clemetson JM, Clemetson KJ, Frey FJ, Frey BM. Presence of lipocortins I and IV, but not II and VI, in human platelets. FEBS Lett 1993; 318:231-4; PMID:8440377
  • Bot I, Shi GP, Kovanen PT. Mast cells as effectors in atherosclerosis. Arterioscler Thromb Vasc Biol 2015; 35:265-71; PMID:25104798; https://doi.org/10.1161/ATVBAHA.114.303570
  • Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 2013; 13:709-21; PMID:23995626; https://doi.org/10.1038/nri3520
  • Bandeira-Melo C, Bonavita AG, Diaz BL, PM ES, Carvalho VF, Jose PJ, Flower RJ, Perretti M, Martins MA. A novel effect for annexin 1-derived peptide ac2-26: reduction of allergic inflammation in the rat. J Pharmacol Exp Ther 2005; 313:1416-22; PMID:15784654; https://doi.org/10.1124/jpet.104.080473
  • Yazid S, Sinniah A, Solito E, Calder V, Flower RJ. Anti-allergic cromones inhibit histamine and eicosanoid release from activated human and murine mast cells by releasing Annexin A1. PLoS One 2013; 8:e58963; PMID:23527056; https://doi.org/10.1371/journal.pone.0058963
  • Ferlazzo V, D'Agostino P, Milano S, Caruso R, Feo S, Cillari E, Parente L. Anti-inflammatory effects of annexin-1: stimulation of IL-10 release and inhibition of nitric oxide synthesis. Int Immunopharmacol 2003; 3:1363-9; PMID:12946433; https://doi.org/10.1016/S1567-5769(03)00133-4
  • Li Y, Cai L, Wang H, Wu P, Gu W, Chen Y, Hao H, Tang K, Yi P, Liu M, et al. Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2. Oncogene 2011; 30:3887-99; PMID:21499310; https://doi.org/10.1038/onc.2011.112
  • Drechsler M, Soehnlein O. The complexity of arterial classical monocyte recruitment. J Innate Immun 2013; 5:358-66; PMID:23571485; https://doi.org/10.1159/000348795
  • Swirski FK. Inflammation and repair in the ischaemic myocardium. Hamostaseologie 2015; 35:34-6; PMID:25375277; https://doi.org/10.5482/HAMO-14-09-0045
  • Rodrigues SF, Granger DN. Leukocyte-mediated tissue injury in ischemic stroke. Curr Med Chem 2014; 21:2130-7; PMID:24372215
  • Solito E, Kamal A, Russo-Marie F, Buckingham JC, Marullo S, Perretti M. A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J 2003; 17:1544-6; PMID:12824302; https://doi.org/10.1096/fj.02-0941fje
  • El Kebir D, Jozsef L, Khreiss T, Pan W, Petasis NA, Serhan CN, Filep JG. Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation. J Immunol 2007; 179:616-22; PMID:17579083
  • Arur S, Uche UE, Rezaul K, Fong M, Scranton V, Cowan AE, Mohler W, Han DK. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell 2003; 4:587-98; PMID:12689596
  • Blume KE, Soeroes S, Keppeler H, Stevanovic S, KretschmerD, Rautenberg M, Wesselborg S, Lauber K. Cleavage of annexin A1 by ADAM10 during secondary necrosis generates a monocytic “find-me” signal. J Immunol 2012; 188:135-45; PMID:22116825; https://doi.org/10.4049/jimmunol.1004073
  • Scannell M, Flanagan MB, deStefani A, Wynne KJ, Cagney G, Godson C, Maderna P. Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol 2007; 178:4595-605; PMID:17372018
  • Maderna P, Yona S, Perretti M, Godson C. Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2-26). J Immunol 2005; 174:3727-33; PMID:15749912
  • Bagnato C, Thumar J, Mayya V, Hwang SI, Zebroski H, Claffey KP, Haudenschild C, Eng JK, Lundgren DH, Han DK. Proteomics analysis of human coronary atherosclerotic plaque: a feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry. Mol Cell Proteomics 2007; 6:1088-102; PMID:17339633; https://doi.org/10.1074/mcp.M600259-MCP200
  • Viiri LE, Full LE, Navin TJ, Begum S, Didangelos A, Astola N, Berge RK, Seppala I, Shalhoub J, Franklin IJ, et al. Smooth muscle cells in human atherosclerosis: proteomic profiling reveals differences in expression of Annexin A1 and mitochondrial proteins in carotid disease. J Mol Cell Cardiol 2013; 54:65-72; PMID:23154128; https://doi.org/10.1016/j.yjmcc.2012.11.002
  • Cheuk BL, Cheng SW. Annexin A1 expression in atherosclerotic carotid plaques and its relationship with plaque characteristics. Eur J Vasc Endovasc Surg 2011; 41:364-71; PMID:21195640; https://doi.org/10.1016/j.ejvs.2010.11.021
  • Fredman G, Kamaly N, Spolitu S, Milton J, Ghorpade D, Chiasson R, Kuriakose G, Perretti M, Farokhzad O, Tabas I. Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. Sci Transl Med 2015; 7:275ra20; PMID:25695999; https://doi.org/10.1126/scitranslmed.aaa1065
  • Swirski FK, Nahrendorf M. Leukocyte behavior inatherosclerosis, myocardial infarction, and heart failure. Science 2013; 339:161-6; PMID:23307733; https://doi.org/10.1126/science.1230719
  • Ginhoux F, Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol 2014; 14:392-404; PMID:24854589; https://doi.org/10.1038/nri3671
  • Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R, Pittet MJ. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007; 204:3037-47; PMID:18025128; https://doi.org/10.1084/jem.20070885
  • Aurora AB, Porrello ER, Tan W, Mahmoud AI, Hill JA, Bassel-Duby R, Sadek HA, Olson EN. Macrophages are required for neonatal heart regeneration. J Clin Invest 2014; 124:1382-92; PMID:24569380; https://doi.org/10.1172/JCI72181
  • Eltzschig HK, Eckle T. Ischemia and reperfusion–from mechanism to translation. Nat Med 2011; 17:1391-401; PMID:22064429; https://doi.org/10.1038/nm.2507
  • La M, D'Amico M, Bandiera S, Di Filippo C, Oliani SM, Gavins FN, Flower RJ, Perretti M. Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action. FASEB J 2001; 15:2247-56; PMID:11641252; https://doi.org/10.1096/fj.01-0196com
  • Gavins FN, Kamal AM, D'Amico M, Oliani SM, Perretti M. Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct. FASEB J 2005; 19:100-2; PMID:15507472; https://doi.org/10.1096/fj.04-2178fje
  • D'Amico M, Di Filippo C, La M, Solito E, McLean PG, Flower RJ, Oliani SM, Perretti M. Lipocortin 1 reduces myocardial ischemia-reperfusion injury by affecting local leukocyte recruitment. FASEB J 2000; 14:1867-9; PMID:11023969; https://doi.org/10.1096/fj.99-0602fje
  • Qin C, Buxton KD, Pepe S, Cao AH, Venardos K, Love JE, Kaye DM, Yang YH, Morand EF, Ritchie RH. Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-A1 and its N-terminal-derived peptide Ac-ANX-A1(2-26). Br J Pharmacol 2013; 168:238-52; PMID:22924634; https://doi.org/10.1111/j.1476-5381.2012.02176.x
  • Ritchie RH, Gordon JM, Woodman OL, Cao AH, Dusting GJ. Annexin-1 peptide Anx-1(2-26) protects adult rat cardiac myocytes from cellular injury induced by simulated ischaemia. Br J Pharmacol 2005; 145:495-502; PMID:15821756; https://doi.org/10.1038/sj.bjp.0706211
  • Perretti M, Chiang N, La M, Fierro IM, Marullo S, Getting SJ, Solito E, Serhan CN. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med 2002; 8:1296-302; PMID:12368905; https://doi.org/10.1038/nm786
  • Deb P, Sharma S, Hassan KM. Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology 2010; 17:197-218; PMID:20074922; https://doi.org/10.1016/j.pathophys.2009.12.001
  • Relton JK, Strijbos PJ, O'Shaughnessy CT, Carey F, Forder RA, Tilders FJ, Rothwell NJ. Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain. J Exp Med 1991; 174:305-10; PMID:1830327
  • Gavins FN, Dalli J, Flower RJ, Granger DN, Perretti M. Activation of the annexin 1 counter-regulatory circuit affords protection in the mouse brain microcirculation. FASEB J 2007; 21:1751-8; PMID:17317721; https://doi.org/10.1096/fj.06-7842com
  • Enlimomab Acute Stroke Trial I. Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial. Neurology 2001; 57:1428-34; PMID:11673584
  • Becker KJ. Anti-leukocyte antibodies: LeukArrest (Hu23F2G) and Enlimomab (R6.5) in acute stroke. Curr Med Res Opin 2002; 18 Suppl 2:s18-22; PMID:12365824

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.